Elsevier

World Neurosurgery

Volume 139, July 2020, Pages 355-360
World Neurosurgery

Case Report
Initial Report of an Intradural Extramedullary Metastasis of a Pancreatic Neuroendocrine Tumor to the Cervical Spine: A Case Report and Review of the Literature

https://doi.org/10.1016/j.wneu.2020.04.120Get rights and content

Background

Pancreatic neuroendocrine tumors (pNETs) are known to frequently metastasize to the liver and lymphatics; however, metastasis to the spine is exceedingly rare. We report the first case of an intradural, extramedullary pNET metastasis to the upper cervical spine.

Case Description

A 75-year-old Hispanic male patient with history of stage IV pNET with metastasis to the liver and lymph nodes and new-onset lymphadenopathy seen on CT of the chest was found on positron emission tomography scan to have a lesion in the cervical spine. The patient was neurologically intact on physical examination, yet given the patient's medical history, magnetic resonance imaging of the cervical spine was performed, revealing a right-sided intradural, extramedullary mass at the C1–C2 level with associated mass effect on the spinal cord, likely representing a schwannoma. Due to the tumor size, mass effect, and the need for definitive tissue diagnosis, a partial C1–C2 laminectomy with intradural resection of the tumor was performed. The histology was consistent with the patient's known pNET.

Conclusions

As treatment for pNETs has evolved, there has been a surge in unique presentations of systemic well-differentiated pNETs being reported. It is vital that patients diagnosed with pNET be monitored for metastases, and when discovered, treated promptly.

Introduction

Neuroendocrine tumors are a diverse group of malignancies defined as epithelial neoplasms with predominant neuroendocrine differentiation.1 These tumors arise from neuroendocrine cells distributed throughout the body; however, two thirds of these tumors are of pancreatic or gastrointestinal origin, with pancreatic or rectal origin entailing a worse prognosis.2 Although pancreatic neuroendocrine tumors (pNETs) have a relatively low incidence of 3 cases per million, they account for about 10% of malignant pancreatic cancers and have shown a steady increase in incidence over the past 3 decades.3,4

pNETs frequently metastasize to the liver, lymphatics, and less frequently to the peritoneum and lungs.5 Metastasis to the spine is exceedingly rare and can lead to spinal cord compression through extramedullary spread of tumor. Although the majority of reported cases of spinal cord compression from metastatic pNET lesions are characterized by extradural spread from a vertebral body lesion, only one other case of an intradural, extramedullary pNET metastasis has been reported to our knowledge in the upper thoracic spine.6 Here we report a 75-year-old male patient with a previous history of stage IV pNET treated with lanreotide injections who presented with an incidentally discovered intradural, extramedullary mass in the cervical spine. The patient was successfully managed with surgical resection of this solitary mass, which was found to be a pNET metastasis, and he was continued on lanreotide injections. To our knowledge, this is the first reported case of an intradural, extramedullary metastasis of a pNET to the upper cervical spine. We discuss the perioperative management as well as a brief review of the literature in regard to pNET spine metastasis.

Section snippets

Case Report

The patient was a 75-year-old man with a history of stage IV pNET with metastasis to the liver and lymph nodes that was originally diagnosed 2 years previously. The patient presented to our outpatient clinic after a positive emission topography (PET) scan, which was performed after precarinal, hilar, and cardiophrenic lymph nodes were noted to be increased in size on computed tomography (CT) of the chest, revealed a mass in the cervical spine. The patient had been successfully treated with

Discussion

The prevalence of spinal metastases has increased significantly in the past 2 decades. This is likely a function of both medical advancements improving the efficacy of cancer treatments and ultimately leading to longer survival times as well as improvements in imaging modalities leading to better detection of metastases.7 Furthermore, the improvement in survival time and surveillance has led to the discovery of metastases in nontraditional locations.

Metastatic spine disease is a frequently

Conclusions

As the efficacy of targeted treatment for pNETs has evolved, there has been a respective increase in prevalence of this disease seen in the population as patients are living longer. This has subsequently led to more unique presentations of systemic well-differentiated pNETs being reported. As the systemic spread of this disease corresponds with a more aggressive disease course, it is vital that patients diagnosed and treated for pNET be monitored for metastases, and when discovered, treated

References (35)

  • N. Cameron Hatrick et al.

    The surgical treatment of metastatic disease of the spine

    Radiother Oncol

    (2000)
  • D.E. Traul et al.

    Part I: Spinal-cord neoplasms—intradural neoplasms

    Lancet Oncol

    (2007)
  • D.P. Beall et al.

    Extramedullary intradural spinal tumors: a pictorial review

    Curr Probl Diagn Radiol

    (2007)
  • K.C.V.G. Rao et al.

    Carcinoid tumor with intradural spinal metastases

    J Comput Tomogr

    (1988)
  • D.S. Klimstra et al.

    The pathologic classification of neuroendocrine tumors

    Pancreas

    (2010)
  • E. González-Flores et al.

    SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

    Clin Transl Oncol

    (2019)
  • J.C. Yao et al.

    One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

    J Clin Oncol

    (2008)
  • D.D. Von Hoff et al.

    Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

    N Engl J Med

    (2013)
  • J.M. O’Connor et al.

    Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study

    Mol Clin Oncol

    (2014)
  • S. Cabezas-Camarero et al.

    C8-T1 radiculopathy due to an intradural extramedullary metastasis of a pancreatic neuroendocrine tumor

    Pancreas

    (2016)
  • J.C. Bailar et al.

    Cancer undefeated

    N Engl J Med

    (1997)
  • A.P. White et al.

    Metastatic disease of the spine

    J Am Acad Orthop Surg

    (2006)
  • V.L. Fornasier et al.

    Metastases to the vertebral column

    Cancer

    (1975)
  • W.B. Jacobs et al.

    Evaluation and treatment of spinal metastases: an overview

    Neurosurg Focus

    (2001)
  • F.M. Khaw et al.

    The appearance on MRI of vertebrae in acute compression of the spinal cord due to metastases

    J Bone Jt Surg

    (1999)
  • A. Di Martino et al.

    Metastatic epidural spinal cord compression

    Expert Rev Anticancer Ther

    (2016)
  • U. Schick et al.

    Intradural and extradural spinal metastases

    Neurosurg Rev

    (2001)
  • Cited by (0)

    Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    4

    Present address for Brian F. Saway: 96 Jonathan Lucas Street, Room: 301, MSC 606, Charleston, SC 29425

    View full text